PressRelease-1999-31

RESEARCH TRIANGLE PARK, NC - September 13, 1999 -- Quintiles Transnational Corp. (Nasdaq: QTRN) today announced the following appointments:

James J. Mauzey has been named Chief Executive Officer of Innovex, succeeding David F. White, whose planned retirement took effect Sept. 1. Innovex, a service group of Quintiles Transnational Corp., is the worldwide leader in providing pharmaceutical and biotechnology companies with integrated solutions to enhance the commercial success of their products.

Mauzey joined the company in March as Chief Operating Officer of Innovex, the position he held upon being named to succeed White. Prior to joining Innovex, Mauzey was Chairman and Chief Executive Officer of Alteon Inc., and before that President of the U.S. Pharmaceutical Division of Bristol-Myers Squibb Company. Mauzey began his career with Lederle Laboratories, where he held increasingly responsible sales and marketing positions, the last as Vice President of Lederle's International Division.

"As the strategic solutions partner to the pharmaceutical industry, Quintiles Transnational relies heavily on the kind of proven industry talent exemplified by Jim Mauzey," said Santo J. Costa, President and Chief Operating Officer of Quintiles Transnational Corp. "In his 27-year pharmaceutical career, Jim has developed the extensive industry experience and contacts that will help us continue the globalization of our commercial efforts."

White will serve as a consultant until January 2000 and remains on the Quintiles Transnational Corp. Board of Directors. As a consultant, he will concentrate primarily on developing QUINTERNET(TM)Informatics applications for the commercialization group in Europe and Asia and on ensuring a smooth leadership transition for Innovex. QUINTERNET(TM)Informatics provides unique market research and healthcare information to pharmaceutical and healthcare customers worldwide.

"We are very grateful for the tremendous contributions David has made to Quintiles," said Costa. "As CEO of our Innovex service group, he has helped expand the globalization of our sales force and secure our position among the top 10 largest sales forces in the pharmaceutical industry worldwide. We look forward to continuing our rewarding association during David's consultancy."

Neil G. MacAllister has been appointed to the newly created position of Senior Vice President, Strategic Corporate Development and Planning. Prior to joining Quintiles, MacAllister was worldwide head of pharmaceutical company consulting activities for IBM. In this position, he also played a key role in determining IBM's overall strategy in healthcare and life sciences. In his distinguished 19-year career, MacAllister also served as a principal in the global pharmaceutical practice of Booz, Allen & Hamilton, providing management consulting advice to many of the major pharmaceutical companies in business strategy and organizational transformation. From 1986 to 1992, he held increasingly responsible positions in International Pharmaceutical Services, a division of Wood MacKenzie's Business Consulting Group. MacAllister began his career as Technical Service Director for NL Chemicals in New Jersey, and later joined Beecham Research Laboratories in the United Kingdom where he occupied positions of increasing responsibility, primarily in sales and marketing.

"Over the past nearly two decades, Neil has developed an outstanding career across a broad spectrum of the healthcare industry," said Costa. "We look forward to working with him as we continue to strengthen our strategic partnernerships with our customers and to develop new product and service offerings that meet their evolving needs."

Steven E. Simpson has been appointed Chief Operating Officer for ENVOY Corporation, the leader in electronic transactions processing for the healthcare industry and a part of the QUINTERNET(TM)Informatics group. Simpson joined ENVOY in November 1998 as Senior Vice President, Sales and Marketing, the position held prior to his appointment as COO. Before that, he was the President and CEO of HealthStat, LLC, an occupational healthcare company in Nashville, Tenn. Previously, he held the position of Senior Vice President of Sales and Product Line Development at Columbia/HCA, where he established the national sales and corporate product line development initiatives to represent Columbia/HCA's provider facilities to various customer segments. Simpson also spent 11 years with Johnson & Johnson, where he held senior level positions in Pharmaceutical Sales, Marketing and Managed Care.

"Steve's far-reaching knowledge of the pharmaceutical and healthcare industries, now combined with operating responsibilities for ENVOY, will greatly enhance the ongoing development of our electronic transactions processing business," said Costa. "We're excited about the continuing growth opportunities of this important healthcare sector."

Quintiles Transnational Corp. is the market leader in providing a full range of integrated product development and commercialization solutions to the pharmaceutical, biotechnology and medical device industries. Quintiles also is a leader in electronic transactions processing and informatics for the healthcare sector and provides healthcare policy consulting to governments and other organizations worldwide.

Headquartered near Research Triangle Park, North Carolina, Quintiles is a member of the Forbes Platinum 400, the Fortune 1000, the Business Week Global 1000, the Nasdaq-100 Index, and the Fortune 100 List of Fastest-Growing Companies. With more than 19,000 employees worldwide and offices in 31 countries, Quintiles operates through specialized work groups dedicated to meeting customers' individual needs.